Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLADOTH for Pediatric Hepatocellular Carcinoma
NCT00276705Phase 2Unknown
- Sponsor
- Children's Cancer and Leukaemia Group
- Start
- Jun 2005
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of thalidomide in hepatocellular carcinoma (HCC), sponsored by Children's Cancer and Leukaemia Group. Status: unknown.
02
Drugs
thalidomide
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00276705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00276705.